Breath Analysis

BREATH CAPTURE RESEARCH & TECHNOLOGY

patent pending

Just Breathe...

Non-invasive

Early Disease Detection

Point-of-Care Technology

Cost Effective

BREATH ANALYSIS

HOW IT WORKS

WHY IT MATTERS

Non-invasive

Early Disease Detection

Point-of-Care Technology

Cost Effective

Imagine a world where your breath could detect your health issues non-invasively. All that you have to do is

Just Breathe...

Hygieia Sciences is making this a reality through the use of patented research and technologies.

patent pending

The patient breathes into a breath capture device.  It is then analyzed for early disease detection screening.  By identifying and tracking patterns for inflammatory metabolic processes with multiple breath volatile organic compound (BVOC) fingerprints, Hygieia Sciences has proven success in distinguishing Breast Cancer, Lung Cancer, Parkinson's Disease, and Alzheimer's Disease in early stages.

More time for you and with your loved ones is the ultimate goal of our non-invasive, breath capture, early disease detection methods.  Being able to identify diseases in some of the earliest stages, which are normally asymptomatic and undiagnosed by the medical profession today, give you or your loved ones a chance for treatment and medical intervention sooner.

Through the easy collection of a patient's breath using Hygieia Sciences' patented Breath Sampling Device, accurate and cost effective gains are made for the medical industry, which is ultimately passed on to the patient.  This is a revolutionary disrupter for the traditional medical testing industry, not requiring the collection of blood, urine, or other specimens, minimizing patient inconvenience and potential use during routine medical screenings.

EARLY DETECTION

Woman with Pink Ribbon

classifying Breast Cancer and a combined study mix of lung and breast cancer differentiation with 88% accuracy

Doctor Using Digital Tablet

classifying Parkinson's Disease from controls among the study group, resulting in 73.5% accuracy for total unknowns, which will continue to increase with additional population studies.

Happy Senior Couple

classifying Alzheimer's mild cognitive (MCI) from controls resulting in 85% accuracy for total unknowns.

100%

Accuracy

98%

Accuracy

95%

Accuracy

© 2023 by Hygieia Sciences, LLC. Proudly created with Ere Design Co., LLC